Gene · 114907
Papers2,920
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,920
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of potassium chloride cotransporters impairs muscle contraction and induces atrophy in C2C12 myotubes. | Biosci Biotechnol Biochem | 2026 | 41294285 | PubTator, text mining | PubMed |
| Comprehensive transcriptomic analysis identifies Lrg1 as a potential therapeutic target for preventing muscle atrophy in cancer cachexia. | Am J Physiol Cell Physiol | 2026 | 41289601 | PubTator, text mining | PubMed |
| Asiatic acid alleviates dexamethasone-induced muscle atrophy through regulating the Sirt1/PGC-1α/FOXO3 pathway. | Histol Histopathol | 2026 | 40985203 | PubTator, text mining | PubMed |
| Valproic acid-based self-assembling nanoparticle prodrugs prevent skeletal muscle loss in cancer cachexia. | Colloids Surf B Biointerfaces | 2026 | 40929761 | PubTator, text mining | PubMed |
| Muscle atrophy following anterior cruciate ligament reconstruction: A narrative review. | Histol Histopathol | 2026 | 40685995 | PubTator, text mining | PubMed |
| Unraveling the metabolic pathways between atherosclerosis and sarcopenia. | Front Endocrinol (Lausanne) | 2025 | 41726101 | PubTator, text mining | PubMed |
| Systematic Exploration of Molecular Mechanisms and Natural Herbal Therapeutic Strategies for Cancer Cachexia. | Cancers (Basel) | 2025 | 41514616 | PubTator, text mining | PubMed |
| IGF2BP3 binds to FBXO32 to activate the cyclic guanosine monophosphate-protein kinase G pathway, promoting gastric cancer progression. | World J Gastroenterol | 2025 | 41479643 | PubTator, text mining | PubMed |
| Glucagon Like Peptide-1 Receptor Agonists for Sarcopenia and Muscle Wasting Disorders: A Systematic Review of Efficacy and Mechanisms. | Aging Dis | 2025 | 41400575 | PubTator, text mining | PubMed |
| Adipose-Muscle Crosstalk in COPD Cachexia: Early Adipose Atrophy Drives Subsequent Muscle Wasting. | J Cachexia Sarcopenia Muscle | 2025 | 41365320 | PubTator, text mining | PubMed |
| Screening of Metabolism-Related Biomarkers and Construction of Prognostic Models in Patients with Neuroblastoma. | Clin Lab | 2025 | 41362189 | PubTator, text mining | PubMed |
| The role of GLP-1 in the pathophysiology and treatment of sepsis: a narrative review. | Front Med (Lausanne) | 2025 | 41357527 | PubTator, text mining | PubMed |
| Theoretical-Experimental Analysis to Elucidate the Mechanism of Action of Novel Anabolic Agents. | Molecules | 2025 | 41302540 | PubTator, text mining | PubMed |
| Oxytocin treatment reduces cancer cachexia in a pre-clinical model. | Biomed Pharmacother | 2025 | 41297427 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome pathway activation in the diaphragm of humans with reflux esophagitis. | Am J Physiol Gastrointest Liver Physiol | 2025 | 41273780 | PubTator, text mining | PubMed |
| Glucagon-like peptide-1 receptor agonists and sarcopenia-related markers in diabetes: A systematic review and meta-analysis. | Clin Nutr | 2025 | 41187492 | PubTator, text mining | PubMed |
| The Brown Bear and Hibernating Mammals as a Translational Model for Human Resilience: Insights for Space Medicine, Critical Care, and Austere Environments. | Biology (Basel) | 2025 | 41154837 | PubTator, text mining | PubMed |
| Muscle-Bone Crosstalk and Metabolic Dysregulation in Children and Young People Affected with Type 1 Diabetes: Mechanisms and Clinical Implications. | Cells | 2025 | 41148826 | PubTator, text mining | PubMed |
| CTRP9 as a myokine mitigates sarcopenia via the LAMP-2A/NLRP3 pathway. | Cell Death Dis | 2025 | 41057318 | PubTator, text mining | PubMed |
| MiR-126-5p Derived From Bone Marrow Mesenchymal Stem Cell Exosomes Promotes Skeletal Muscle Regeneration by Regulating FBXO32/MyoD Signaling. | Acta Physiol (Oxf) | 2025 | 41025492 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/114907/papers?page=5